Cargando…
Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees
The efforts toward individualized medicine have constantly increased in an attempt to improve treatment options. These efforts have led to the development of small molecules which target specific molecular pathways involved in cancer progression. We have reviewed preclinical studies of sunitinib tha...
Autores principales: | Segarra, Ignacio, Modamio, Pilar, Fernández, Cecilia, Mariño, Eduardo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519571/ https://www.ncbi.nlm.nih.gov/pubmed/28785221 http://dx.doi.org/10.3389/fphar.2017.00488 |
Ejemplares similares
-
Precision Medicine and the Institutional Review Board: Ethics and the Genome
por: Matrana, Marc R., et al.
Publicado: (2020) -
A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials
por: Rose, Klaus, et al.
Publicado: (2015) -
Are trial participants adequately safeguarded by the ethics committees—the Indian scenario?
por: Thakkar, Karan, et al.
Publicado: (2014) -
Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines
por: Mestorino, Nora, et al.
Publicado: (2016) -
At What Level of Collective Equipoise Does a Randomized Clinical Trial Become Ethical for the Members of Institutional Review Board/Ethical Committees?
por: Mhaskar, Rahul, et al.
Publicado: (2013)